Candel Therapeutics (CADL) Short term Debt (2023 - 2025)
Candel Therapeutics (CADL) posted Short term Debt of $4.2 million for Q3 2025, down 36.98% sequentially from $6.7 million in Q2 2025, and down 57.11% YoY from $9.9 million in Q3 2024.
Candel Therapeutics (CADL) Short term Debt (2023 - 2025) Analysis & Trends
Candel Therapeutics has reported Short term Debt for 3 years, with the latest figure at $4.2 million in Q3 2025.
- Quarterly Short term Debt fell 57.11% year-over-year to $4.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.2 million (down 57.11% YoY) and the FY2024 annual result came in at $9.9 million, up 11.27% from the prior year.
- Short term Debt slipped to $4.2 million in Q3 2025 per CADL's latest filing, from $6.7 million in the prior quarter.
- Over five years, Short term Debt peaked at $9.9 million in Q4 2024 and troughed at $1.3 million in Q1 2023.
- A 3-year average of $7.2 million and a median of $8.9 million in 2023 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2024 and 2025: Short term Debt jumped 679.49% in 2024, then tumbled 57.11% in 2025.
- Over 3 years, Short term Debt stood at $8.9 million in 2023, then advanced by 11.27% to $9.9 million in 2024, then plunged by 57.3% to $4.2 million in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $4.2 million, $6.7 million, and $9.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 9.17 Mn |
| Dec 31, 2024 | 9.90 Mn |
| Sep 30, 2024 | 9.85 Mn |
| Jun 30, 2024 | 9.81 Mn |
| Mar 31, 2024 | 9.77 Mn |
| Dec 31, 2023 | 8.89 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 1.25 Mn |